Brain Therapeutics is a Central Nervous System Specialty Company focused on three Therapeutic areas:

Psychiatry,

Neurology and

Pain.

Brain Therapeutics specializes in in-licensing and commercializing approved products from Central Nervous System Sector to address the unmet medical needs of patients with Brain Disorders, such as Mood and Anxiety diseases, Schizophrenia and Bipolar Disorder, Parkinson’s and Epilepsy, as well as Pain.

Our initial focus is on products for Psychiatrists, Neurologists and Anaesthesiologists working in Pain Centres.
Headquartered in Athens, Brain Therapeutics has long expertise of commercialization of CNS products not only in Greece but also in Balkan and Eastern Europe countries

Brain Therapeutics’ team is built by successful and respected professionals with strong commercial capabilities, proven track record of commercial success in CNS area, dedicated to bringing therapies to the patients with Mood and Anxiety Diseases, Schizophrenia and Bipolar Disorder, Parkinson’s and Epilepsy, as well as Pain.

Brain Therapeutics’ team has more than 20 years’ experience within Brain Disorders and commercial capabilities acquired through years of experience in multinational pharma. In addition, the team has a strong network among CNS key opinion leaders and all these years is dedicated to Brain Disorders.

Brain Therapeutics
covers high unmet need in sophisticated CNS area.
Due to expertise and knowledge of marketing and commercialization of CNS products in multinational pharmaceutical companies, is the ideal partner offering a flexible approach to partnerships and collaborations.